| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Division of Biology of Growth and Reproduction, Department of
Pediatrics, University of Geneva School of Medicine (P.D.R., P.B.,
D.D.P., M.L.A.), 1211 Geneva 14, Switzerland; Ferring Research Ltd.
(P.D.R., P.B., D.D.P., A.H., J.-L.J.), Chilworth, United Kingdom SO17
7NP; Instituto Tecnológico e Nuclear (P.D.R.), 2685 Sacavem,
Portugal; and Douglass Hospital Research Center, Department of
Psychiatry, McGill University (Y.D., R.Q.), Verdun, Québec,
Canada H4H 1R3
1
Address all correspondence and requests for reprints to: Dr. M. L. Aubert, Hopital des Enfants, Hôpitaux Universitaires de Genève, 6 rue Willy-Donzé, 1211 Geneva 14, Switzerland. E-mail: aubert{at}cmu unige.ch.
A number of studies have indicated that neuropeptide Y (NPY) is a central regulator of the gonadotropic axis, and the Y1 receptor was initially suggested to be implicated. As at least five different NPY receptor subtypes have now been characterized, the aim of the present study was to reinvestigate the pharmacological profile of the receptor(s) mediating the inhibitory action of NPY on LH secretion by using a panel of NPY analogs with different selectivity toward the five NPY receptor subtypes. When given intracerebroventricularly (icv) to castrated rats, a bolus injection of native NPY (0.72.3 nmol) dose-dependently decreased plasma LH. Peptide YY (PYY; 2.3 nmol) was as potent as NPY, suggesting that the Y3 receptor is not implicated. Confirming previous data, the mixed Y1, Y4, and Y5 agonist [Leu31,Pro34]NPY (0.72.3 nmol) inhibited LH release with potency and efficacy equal to those of NPY. Neither the selective Y2 agonist C2-NPY (2.3 nmol) nor the selective Y4 agonist rat pancreatic polypeptide affected plasma LH, excluding Y2 and Y4 subtypes for the action of NPY on LH secretion. The mixed Y4-Y5 agonist human pancreatic polypeptide (0.77 nmol) as well as the mixed Y2-Y5 agonist PYY336 (0.77 nmol) that displayed very low affinity for the Y1 receptor, thus practically representing selective Y5 agonists in this system, decreased plasma LH with potency and efficacy similar to those of NPY, indicating that the Y5 receptor is mainly involved in this inhibitory action of NPY on LH secretion. [D-Trp32]NPY, a selective, but weak, Y5 agonist, also inhibited plasma LH at a dose of 7 nmol. Furthermore, the inhibitory action of NPY (0.7 nmol) on LH secretion could be fully prevented, in a dose-dependent manner (6100 µg, icv), by a nonpeptidic Y5 receptor antagonist. This antagonist (60 µg, icv) also inhibited the stimulatory action of NPY (0.7 nmol) on food intake. The selectivity of PYY336, human PP, [D-Trp32]NPY, and the Y5 antagonist for the Y5 receptor subtype was further confirmed by their ability to inhibit the specific [125I][Leu31,Pro34]PYY binding to rat brain membrane homogenates in the presence of the Y1 receptor antagonist BIBP3226, a binding assay system that was described as being highly specific for Y5-like receptors. With the exception of [D-Trp32]NPY, all analogs able to inhibit LH secretion were also able to stimulate food intake. Taken together, these results indicate that the Y5 receptor is involved in the negative control by NPY of the gonadotropic axis.
This article has been cited by other articles:
![]() |
J. Xu, M. A. Kirigiti, K. L. Grove, and M. S. Smith Regulation of Food Intake and Gonadotropin-Releasing Hormone/Luteinizing Hormone during Lactation: Role of Insulin and Leptin Endocrinology, September 1, 2009; 150(9): 4231 - 4240. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Budki, S. Rani, and V. Kumar Food deprivation during photosensitive and photorefractory life-history stages affects the reproductive cycle in the migratory Red-headed Bunting (Emberiza bruniceps) J. Exp. Biol., January 15, 2009; 212(2): 225 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, M. A. Kirigiti, M. A. Cowley, K. L. Grove, and M. S. Smith Suppression of Basal Spontaneous Gonadotropin-Releasing Hormone Neuronal Activity during Lactation: Role of Inhibitory Effects of Neuropeptide Y Endocrinology, January 1, 2009; 150(1): 333 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pinilla, R. Fernandez-Fernandez, J. Roa, J. M. Castellano, M. Tena-Sempere, and E. Aguilar Selective role of neuropeptide Y receptor subtype Y2 in the control of gonadotropin secretion in the rat Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1385 - E1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kakui and K. Kitamura Direct Evidence that Stimulation of Neuropeptide Y Y5 Receptor Activates Hypothalamo-Pituitary-Adrenal Axis in Conscious Rats via both Corticotropin-Releasing Factor- and Arginine Vasopressin-Dependent Pathway Endocrinology, June 1, 2007; 148(6): 2854 - 2862. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lin, E.-J. D. Lin, D. Boey, N. J. Lee, K. Slack, M. J. During, A. Sainsbury, and H. Herzog Fasting Inhibits the Growth and Reproductive Axes via Distinct Y2 and Y4 Receptor-Mediated Pathways Endocrinology, May 1, 2007; 148(5): 2056 - 2065. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pinilla, R. Fernandez-Fernandez, E. Vigo, V. M. Navarro, J. Roa, J. M. Castellano, R. Pineda, M. Tena-Sempere, and E. Aguilar Stimulatory effect of PYY-(3-36) on gonadotropin secretion is potentiated in fasted rats Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1162 - E1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kakui, J. Tanaka, Y. Tabata, K. Asai, N. Masuda, T. Miyara, Y. Nakatani, F. Ohsawa, N. Nishikawa, M. Sugai, et al. Pharmacological Characterization and Feeding-Suppressive Property of FMS586 [3-(5,6,7,8-Tetrahydro-9-isopropyl-carbazol-3-yl)-1-methyl-1-(2-pyridin-4-yl-ethyl)-urea Hydrochloride], a Novel, Selective, and Orally Active Antagonist for Neuropeptide Y Y5 Receptor J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 562 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, and C. Y. Bowers Somatotropic and Gonadotropic Axes Linkages in Infancy, Childhood, and the Puberty-Adult Transition Endocr. Rev., April 1, 2006; 27(2): 101 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kobashi, Y. Shimatani, K. Shirota, S.-Y. Xuan, Y. Mitoh, and R. Matsuo Central neuropeptide Y induces proximal stomach relaxation via Y1 receptors in the dorsal vagal complex of the rat Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2006; 290(2): R290 - R297. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Vulliemoz, E. Xiao, L. Xia-Zhang, S. L. Wardlaw, and M. Ferin Central Infusion of Agouti-Related Peptide Suppresses Pulsatile Luteinizing Hormone Release in the Ovariectomized Rhesus Monkey Endocrinology, February 1, 2005; 146(2): 784 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Clarke, K. Backholer, and A. J. Tilbrook Y2 Receptor-Selective Agonist Delays the Estrogen-Induced Luteinizing Hormone Surge in Ovariectomized Ewes, but Y1-Receptor-Selective Agonist Stimulates Voluntary Food Intake Endocrinology, February 1, 2005; 146(2): 769 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Wade and J. E. Jones Neuroendocrinology of nutritional infertility Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1277 - R1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. G. Halatchev, K. L. J. Ellacott, W. Fan, and R. D. Cone Peptide YY3-36 Inhibits Food Intake in Mice through a Melanocortin-4 Receptor-Independent Mechanism Endocrinology, June 1, 2004; 145(6): 2585 - 2590. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Raposinho, T. Pedrazzini, R. B. White, R. D. Palmiter, and M. L. Aubert Chronic Neuropeptide Y Infusion into the Lateral Ventricle Induces Sustained Feeding and Obesity in Mice Lacking Either Npy1r or Npy5r Expression Endocrinology, January 1, 2004; 145(1): 304 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abizaid, D. Kyriazis, and B. Woodside Effects of leptin administration on lactational infertility in food-restricted rats depend on milk delivery Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2004; 286(1): R217 - R225. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Turi, Z. Liposits, S. M. Moenter, C. Fekete, and E. Hrabovszky Origin of Neuropeptide Y-Containing Afferents to Gonadotropin-Releasing Hormone Neurons in Male Mice Endocrinology, November 1, 2003; 144(11): 4967 - 4974. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Campbell, K. L. Grove, and M. S. Smith Gonadotropin-Releasing Hormone Neurons Coexpress Orexin 1 Receptor Immunoreactivity and Receive Direct Contacts by Orexin Fibers Endocrinology, April 1, 2003; 144(4): 1542 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Galas, M.-C. Tonon, D. Beaujean, R. Fredriksson, D. Larhammar, I. Lihrmann, S. Jegou, A. Fournier, N. Chartrel, and H. Vaudry Neuropeptide Y Inhibits Spontaneous {alpha}-Melanocyte-Stimulating Hormone ({alpha}-MSH) Release via a Y5 Receptor and Suppresses Thyrotropin-Releasing Hormone-Induced {alpha}-MSH Secretion via a Y1 Receptor in Frog Melanotrope Cells Endocrinology, May 1, 2002; 143(5): 1686 - 1694. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Jervis and B. Robaire Dynamic Changes in Gene Expression along the Rat Epididymis Biol Reprod, September 1, 2001; 65(3): 696 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ichimaru, Y. Mori, and H. Okamura A Possible Role of Neuropeptide Y as a Mediator of Undernutrition to the Hypothalamic Gonadotropin-Releasing Hormone Pulse Generator in Goats Endocrinology, June 1, 2001; 142(6): 2489 - 2498. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Corp, B. Greco, J. B. Powers, C. L. M. Bivens, and G. N. Wade Neuropeptide Y inhibits estrous behavior and stimulates feeding via separate receptors in Syrian hamsters Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1061 - R1068. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Terasawa and D. L. Fernandez Neurobiological Mechanisms of the Onset of Puberty in Primates Endocr. Rev., February 1, 2001; 22(1): 111 - 151. [Abstract] [Full Text] |
||||
![]() |
P. D. Raposinho, E. Castillo, V. D'alleves, P. Broqua, F. P. Pralong, and M. L. Aubert Chronic Blockade of the Melanocortin 4 Receptor Subtype Leads to Obesity Independently of Neuropeptide Y Action, with No Adverse Effects on the Gonadotropic and Somatotropic Axes Endocrinology, December 1, 2000; 141(12): 4419 - 4427. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Lebrethon, E. Vandersmissen, A. Gerard, A. S. Parent, J. L. Junien, and J. P. Bourguignon In Vitro Stimulation of the Prepubertal Rat Gonadotropin-Releasing Hormone Pulse Generator by Leptin and Neuropeptide Y through Distinct Mechanisms Endocrinology, April 1, 2000; 141(4): 1464 - 1469. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |